Stay updated on CM-24 Combo Study With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.

Latest updates to the CM-24 Combo Study With Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page's content history. This change records a new revision of the Study Details page without altering study data or outcomes.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision indicator was updated from v3.6.4 to v3.6.5, representing a small metadata update to the page.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now shows revision v3.6.4, updating the version label from v3.6.3.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3, indicating a minor frontend update; no study data or page content changes are reflected.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page adds guidance and join-related sections to assist potential participants, and updates the recruitment status; it also includes a formatting tweak to the Intervention/Treatment header and updates the site revision to v3.6.0.SummaryDifference0.4%

- Check97 days agoChange DetectedThe page's revision label has changed from v3.5.4 to v3.5.5, indicating a small internal update to the revision history. No substantive content or data on the page appears to be affected.SummaryDifference0.0%

Stay in the know with updates to CM-24 Combo Study With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.